Solid Biosciences is merging with Sarepta-backed AavantiBio in a $215m deal while Amazon has formed a minority founder-focused $150m fund.
M&A
Nasdaq-listed Duchenne muscular dystrophy therapy developer Solid Biosciences is merging with AavantiBio, a US-based gene therapeutics provider backed by genetic medicine group Sarepta Therapeutics, through a $215m cash and investment deal.
Business management automation tool provider ZenBusiness has acquired Ureeka, a US-based minority founder-focused mentoring platform backed by enterprise software firm Salesforce, for an undisclosed amount.
Cosmetics firm Shiseido has agreed to acquire Gallinée, a…
